View in EDS

Trough dabrafenib plasma concentrations can predict occurrence of adverse events requiring dose reduction in metastatic melanoma.

Saved in:
Bibliographic Details
Title: Trough dabrafenib plasma concentrations can predict occurrence of adverse events requiring dose reduction in metastatic melanoma.
Authors: Rousset M; Département de Pharmacologie, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France; Univ. Bordeaux INSERM, Bordeaux Population Health Research Center, team PHARMACOEPIDEMIOLOGY, UMR 1219, F-33000 Bordeaux, France. Electronic address: marine.rousset@u-bordeaux.fr., Dutriaux C; Département de Dermatologie, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France., Bosco-Lévy P; Département de Pharmacologie, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France; Univ. Bordeaux INSERM, Bordeaux Population Health Research Center, team PHARMACOEPIDEMIOLOGY, UMR 1219, F-33000 Bordeaux, France., Prey S; Département de Dermatologie, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France., Pham-Ledard A; Département de Dermatologie, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France; EA2406 Histology and Molecular Pathology of Tumors, University of Bordeaux, F-33000, France., Dousset L; Département de Dermatologie, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France., Gérard E; Département de Dermatologie, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France., Bouchet S; Département de Pharmacologie, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France; Univ. Bordeaux INSERM, Bordeaux Population Health Research Center, team PHARMACOEPIDEMIOLOGY, UMR 1219, F-33000 Bordeaux, France., Canal-Raffin M; Département de Pharmacologie, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France; Univ. Bordeaux INSERM, Bordeaux Population Health Research Center, team Cancer-environnement-EPICENE, UMR 1219, F-33000 Bordeaux, France., Titier K; Département de Pharmacologie, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France., Molimard M; Département de Pharmacologie, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France; Univ. Bordeaux INSERM, Bordeaux Population Health Research Center, team PHARMACOEPIDEMIOLOGY, UMR 1219, F-33000 Bordeaux, France. Electronic address: mathieu.molimard@u-bordeaux.fr.
Source: Clinica chimica acta; international journal of clinical chemistry [Clin Chim Acta] 2017 Sep; Vol. 472, pp. 26-29. Date of Electronic Publication: 2017 Jul 12.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 1302422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-3492 (Electronic) Linking ISSN: 00098981 NLM ISO Abbreviation: Clin Chim Acta Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1873-3492
DOI:10.1016/j.cca.2017.07.012